Story thread · 2 reports / 2 sources
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?
investors.com · 5d · first report
LB Pharmaceuticals is on a tear. The IPO stock has more than tripled as investors watch its efforts in neuropsychiatric disorders. The post IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target? appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.